Human Leukocyte Antigen-A*2402-Restricted Tumor Vessel Specific Peptide Vaccination for Advanced Pancreatic Cancer - Contacts and Locations

Human Leukocyte Antigen-A*2402-Restricted Tumor Vessel Specific Peptide Vaccination for Advanced Pancreatic Cancer

This study is currently recruiting participants.

Study NCT00683358. Last updated on May 22, 2008. Information provided by Tokyo University

Please refer to this study by its ClinicalTrials.gov identifier: NCT00683358

Contacts


Contact: Hitomi Nagayama, MD,PhD	81-3-5449-5772 ext 75185	zephyrus@ims.u-tokyo.ac.jp

Contact: Nagayama

Locations


Japan, Tokyo
	Research Hospital, The Institute of Medical Science, The University of Tokyo	Recruiting
	Minato-ku, Tokyo, Japan, 108-8639
	Principal Investigator: Hitomi Nagayama, MD,PhD

Sponsors and Collaborators

Tokyo University

Human Genome Center, Institute of Medical Science, University of Tokyo

Investigators


Study Director:	Naohide Yamashita, MD, PhD	Director, Research Hospital, Institute of Medical Science, Tokyo University